We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+16.7%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$77.4B
AUM Growth
+$4.82B
Cap. Flow
-$6.74B
Cap. Flow %
-8.71%
Top 10 Hldgs %
8.98%
Holding
4,169
New
447
Increased
1,310
Reduced
1,599
Closed
617

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$436M
2
ABBV icon
AbbVie
ABBV
+$407M
3
JNJ icon
Johnson & Johnson
JNJ
+$295M
4
GILD icon
Gilead Sciences
GILD
+$267M
5
SBUX icon
Starbucks
SBUX
+$230M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$407M
2
BKNG icon
Booking.com
BKNG
+$400M
3
C icon
Citigroup
C
+$314M
4
SHPG
Shire pic
SHPG
+$276M
5
PYPL icon
PayPal
PYPL
+$257M

Sector Composition

Rank Sector Weight
1 Technology 17.04%
2 Healthcare 13.44%
3 Consumer Discretionary 13.38%
4 Financials 7.19%
5 Industrials 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUX icon
3476
McEwen Inc
MUX
$1.29B
$47K ﹤0.01%
3,116
-12,376
-80% -$219K
XNET
3477
Xunlei
XNET
$316M
$47K ﹤0.01%
12,900
-16,026
-55% -$59.6K
UPL
3478
PUT
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$46K ﹤0.01%
75,000
MTNB icon
3479
Matinas BioPharma
MTNB
$2.89M
$43K ﹤0.01%
793
-89
-10% -$4.79K
BRACW
3480
DELISTED
Black Ridge Acquisition Corp. Warrant
BRACW
$41K ﹤0.01%
138,000
-9,449
-6% -$2.75K
ALT icon
3481
Altimmune
ALT
$605M
$38K ﹤0.01%
13,100
VATE icon
3482
INNOVATE Corp
VATE
$102M
$35K ﹤0.01%
1,428
RAD
3483
DELISTED
Rite Aid Corporation
RAD
$34K ﹤0.01%
2,652
-69
-3% -$1.06K
MMDMR
3484
DELISTED
Modern Media Acquisition Corp. Right
MMDMR
$33K ﹤0.01%
100,000
-15,300
-13% -$4.22K
UPL
3485
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$33K ﹤0.01%
54,740
-96,160
-64% -$70.1K
BRS
3486
DELISTED
Bristow Group, Inc.
BRS
$32K ﹤0.01%
28,840
-118,899
-80% -$259K
SRRA
3487
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$30K ﹤0.01%
435
-40
-8% -$2.57K
FTD
3488
DELISTED
FTD Companies, Inc. Common Stock
FTD
$29K ﹤0.01%
56,808
-146,244
-72% -$255K
MMDMW
3489
DELISTED
Modern Media Acquisition Corp. Warrant
MMDMW
$28K ﹤0.01%
89,000
PDS
3490
Precision Drilling
PDS
$1.13B
$26K ﹤0.01%
542
-3,590
-87% -$162K
IBRX icon
3491
ImmunityBio
IBRX
$8.03B
$23K ﹤0.01%
14,708
-165,887
-92% -$208K
GPL
3492
DELISTED
Great Panther Mining Limited
GPL
$23K ﹤0.01%
+2,402
New +$20.1K
HOS
3493
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$23K ﹤0.01%
18,934
SSI
3494
DELISTED
Stage Stores Inc
SSI
$20K ﹤0.01%
19,106
HK
3495
DELISTED
Halcon Resources Corporation
HK
$20K ﹤0.01%
+14,676
New +$23.7K
INFI
3496
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$19K ﹤0.01%
+10,210
New +$14.9K
TNK icon
3497
Teekay Tankers
TNK
$3.19B
$18K ﹤0.01%
2,299
GEN
3498
DELISTED
Genesis Healthcare, Inc.
GEN
$17K ﹤0.01%
11,878
-542,665
-98% -$805K
AMR
3499
DELISTED
Alta Mesa Resources Inc
AMR
$11K ﹤0.01%
43,000
-16,813
-28% -$12.7K
CTIC
3500
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$11K ﹤0.01%
11,302

Similar funds

David Shaw's Q1 2019 Portfolio in Review

As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, David Shaw opened a new position in Lyft worth $159M.

  • David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
  • David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
  • David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
  • David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
  • David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
  • David Shaw opened 447 new positions and closed 617 in Q1 2019.
  • David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.

Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.